FiercePharma

U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE ...

· Eliquis demonstrated noninferiority in the primary efficacy endpoint of recurrent symptomatic venous thromboembolism (VTE) or VTE-related death versus enoxaparin/warfarin in the AMPLIFY trial · ...
FiercePharma

European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE

European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE In the AMPLIFY trial, Eliquis was ...
Healio

FDA approves Eliquis for treatment of DVT, PE

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a supplemental new drug application for apixaban, an oral selective Factor Xa inhibitor, ...
Nasdaq

Findings Released from Real-World Data Analysis of Eliquis (apixaban) for the Treatment of Venous Thromboembolism in Patients with Active Cancer

Results highlighted in two oral presentations at the American Society of Hematology Annual Meeting In a second oral presentation, results from a sub-group analysis of the primary study were ...
Nasdaq

Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)

Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb ...
techtimes

FDA approves Eliquis for leg, lung blood clot treatment

The U.S. Food and Drug Administration (FDA) approved Eliquis use for the treatment and risk reduction of recurring DVT and PE conditions, drug maker Bristol-Myers Squibb said in a statement on Aug. 21 ...
AOL

On Eliquis? This Common OTC Med Could Raise the Risk of Side Effects

It's an extremely common and effective medication used to prevent and break up blood clots and as part of a treatment protocol for atrial fibrillation (AFib). But does Eliquis have side effects? We ...
Monthly Prescribing Reference

FDA to Review Eliquis sNDA for DVT/PE Treatment

The sNDA submission was based on results from two Phase 3 trials, AMPLIFY and AMPLIFY-EXT. AMPLIFY (Apixaban for the initial Management of PuLmonary embolIsm and deep vein thrombosis as First-line ...
Medscape

AVERROES published: Apixaban cuts stroke risk in AF when warfarin isn't an option

The study, known as the Apixaban versus Acetylsalicylic Acid to Prevent Strokes in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment (AVERROES) trial, ...

Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company

"The BMS-Pfizer Alliance is pleased to expand our direct-to-patient options for accessing Eliquis — a medicine relied upon by millions of Americans daily — to the popular Cost Plus Drugs platform," ...
Business Wire

Findings Released from Real-World Data Analysis of Eliquis (apixaban) for the Treatment of Venous Thromboembolism in Patients with Active Cancer

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--The Bristol-Myers Squibb-Pfizer Alliance today announced results from retrospective real-world data analyses reporting outcomes on the safety and ...